Zimmer Biomet Holdings Operating Income increased by 141.6% to $373.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.7%, from $292.30M to $373.20M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 6.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $224.80M | $243.00M | $133.80M | $198.40M | $280.90M | $245.30M | $0.00 | $327.30M | $329.60M | $266.60M | $354.20M | $265.90M | $351.30M | $279.50M | $389.00M | $292.30M | $300.00M | $351.30M | $154.50M | $373.20M |
| QoQ Change | — | +8.1% | -44.9% | +48.3% | +41.6% | -12.7% | -100.0% | — | +0.7% | -19.1% | +32.9% | -24.9% | +32.1% | -20.4% | +39.2% | -24.9% | +2.6% | +17.1% | -56.0% | +141.6% |
| YoY Change | — | — | — | — | +25.0% | +0.9% | -100.0% | +65.0% | +17.3% | +8.7% | — | -18.8% | +6.6% | +4.8% | +9.8% | +9.9% | -14.6% | +25.7% | -60.3% | +27.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Americas | $636.80M | $605.30M | $695.00M | $508.50M | $652.80M | $646.50M | $722.70M | $529.30M |
| EMEA | $151.60M | $123.80M | $164.10M | $150.50M | $158.50M | $121.80M | $166.10M | $152.20M |
| Asia Pacific | $122.20M | $123.40M | $122.10M | $88.80M | $122.90M | $116.60M | $117.20M | $93.00M |
| Corporate Items | -$412.40M | -$421.80M | — | — | — | — | — | — |
| Total | $351.30M | $279.50M | $389.00M | $292.30M | $300.00M | $351.30M | $154.50M | $373.20M |
Corporate Items was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.